Malic enzyme 1 (ME1) is a cytosolic protein that catalyzes the conversion of malate to
pyruvate while concomitantly generating NADPH from NADP. Early studies identified ME1 …

Simple Summary ALCAM (activated leukocyte cell adhesion molecule) is an important
regulator in human cancers, particularly solid tumours. Its expression in cancer tissues has …

Laryngeal squamous cell carcinoma (LSCC) is one of the common malignant tumors in the
head and neck region, and its high migration and invasion seriously threaten the survival …

Laryngeal squamous cell carcinoma (LSCC) is one of the most commonly seen cancers in
the head and neck region with increasing morbidity and mortality globally. N6 …

Head and neck squamous cell carcinoma (HNSCC) is a heterogeneous group of tumors that
affect different anatomical locations. Despite this heterogeneity, HNSCC treatment depends …

Laryngeal squamous cell carcinoma (LSCC) is an aggressive and lethal malignant
neoplasm with extremely poor prognoses. Accumulating evidence has indicated that …

Objective: This study aims to construct a systematic mRNA-miRNA-lncRNA network to
identify novel lncRNAs and miRNAs biomarkers for laryngeal squamous cell carcinoma …

Malic enzyme (ME) genes are key functional metabolic enzymes playing a crucial role in
carcinogenesis. However, the detailed effects of ME gene expression on breast cancer …

Laryngeal Squamous Cell Carcinoma: Potential Molecular Mechanism and Prognostic
Signature Based on Immune-Related Genes - PMC Back to Top Skip to main content NIH …

Background Laryngeal squamous cell carcinoma (LSCC) is the second most frequent head
and neck tumor. Prognosis of patients with LSCC has not improved in recent decades …